Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1582.887
- +15.684+1.00%
Close Nov 22 16:00 ET
1592.719High1576.396Low
1581.372Open1567.203Pre Close61.18MVolume6Rise58.13P/E (Static)5.82BTurnover--Flatline0.58%Turnover Ratio1.49TMarket Cap1Fall1.35TFloat Cap
Constituent Stocks: 7Top Rising: GPCR+11.00%
$Baxter International Inc (BAX.US)$
$Fresenius Medical Care (FMS.US)$
$Rockwell Medical (RMTI.US)$ (adj ind.)
$Compass Minerals (CMP.US)$
(chemical for saline)
ADD meds:
$Teva Pharmaceutical Industries (TEVA.US)$
$Pfizer (PFE.US)$
$Cingulate (CING.US)$
EVH (endoscopic vessel harvesting) device shortage:
$TransMedics (TMDX.US)$
$Artivion (AORT.US)$
$Lantheus (LNTH.US)$
$Haemonetics (HAE.US)$
BGM (Blood glucose monitor) device shortage:
$DexCom (DXCM.US)$ $
$Abbott Laboratories (ABT.US)$
...
New Positions
$Taiwan Semiconductor (TSM.US)$ , $Broadcom (AVGO.US)$ , $Johnson & Johnson (JNJ.US)$ , $Pfizer (PFE.US)$ , $Coca-Cola (KO.US)$ , $Occidental Petroleum (OXY.US)$
Sold out Positions
$Disney (DIS.US)$
Increased Positions
$Novo-Nordisk A/S (NVO.US)$ , $AstraZeneca (AZN.US)$ , $Huntington Ingalls Industries (HII.US)$
Decreased Positions
None
loading...
To quietly take down LLY!
It’s good to see the stock is on the rebound. The strong 3rd quarter earnings and higher EPS guidance justified for higher share price. The short term market noise should be ignored. Buy and hold long term will pay off.
PFE has been hammered for a longtime.
TA is showing possible recovery
Earnings just didn't just beat estimate but it blew it away
MM might have wiped out all the bulls by now.
No comment yet